• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.耐利福平临床结核分枝杆菌分离株中I簇区域内外rpoB基因突变的频率。
J Clin Microbiol. 2001 Jan;39(1):107-10. doi: 10.1128/JCM.39.1.107-110.2001.
2
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.结核分枝杆菌临床分离株耐药性的分子机制
Chin Med J (Engl). 1999 Jun;112(6):524-8.
3
Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.利用变性梯度凝胶电泳检测结核分枝杆菌中与利福平耐药相关的rpoB基因突变
Antimicrob Agents Chemother. 2005 Jun;49(6):2200-9. doi: 10.1128/AAC.49.6.2200-2209.2005.
4
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay.西班牙耐利福平结核分枝杆菌分离株rpoB基因的突变及其通过聚合酶链反应-酶联免疫吸附测定法的快速检测
J Clin Microbiol. 2001 May;39(5):1813-8. doi: 10.1128/JCM.39.5.1813-1818.2001.
5
rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis.rpoB基因突变作为耐利福平结核分枝杆菌的流行病学标志物
Int J Tuberc Lung Dis. 2000 Aug;4(8):765-70.
6
[Molecular mutations of rpoB gene of multidrug resistant Mycobacterium tuberculosis isolates from China].[来自中国的耐多药结核分枝杆菌分离株rpoB基因的分子突变]
Yi Chuan Xue Bao. 2004 Dec;31(12):1332-6.
7
[Characterization of rpoB mutation in rifampin - resistant clinical Mycobacterium tuberculosis isolates from China].[中国耐利福平临床结核分枝杆菌分离株中rpoB基因突变的特征分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2001 Apr;24(4):231-5.
8
Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.突尼斯结核分枝杆菌耐利福平临床分离株的特征分析
J Clin Microbiol. 2007 Sep;45(9):3095-7. doi: 10.1128/JCM.00643-07. Epub 2007 Jul 25.
9
Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.使用高密度DNA探针阵列检测结核分枝杆菌中利福平耐药相关突变。
Clin Microbiol Infect. 2004 Apr;10(4):289-94. doi: 10.1111/j.1198-743X.2004.00889.x.
10
Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.巴西耐异烟肼结核分枝杆菌分离株中katG基因Ser315位点替换及rpoB基因突变的流行情况
Int J Tuberc Lung Dis. 2005 Jan;9(1):87-93.

引用本文的文献

1
An additional proofreader contributes to DNA replication fidelity in mycobacteria.另一个校对员有助于分枝杆菌中的 DNA 复制保真度。
Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2322938121. doi: 10.1073/pnas.2322938121. Epub 2024 Aug 14.
2
Molecular Characteristics and Prevalence of Rifampin Resistance in Isolates from Patients with Bacteremia in South Korea.韩国菌血症患者分离株中利福平耐药的分子特征及流行情况
Antibiotics (Basel). 2023 Oct 4;12(10):1511. doi: 10.3390/antibiotics12101511.
3
A pro-oxidant property of vitamin C to overcome the burden of latent infection: A cross-talk review with Fenton reaction.维生素 C 的促氧化剂特性可克服潜伏性感染的负担:与芬顿反应的交叉对话综述。
Front Cell Infect Microbiol. 2023 Apr 19;13:1152269. doi: 10.3389/fcimb.2023.1152269. eCollection 2023.
4
Consequences of mutations missed by the GenoType MTBDR assay in a programmatic setting in South Africa.在南非的一个项目环境中,GenoType MTBDR检测遗漏的突变的后果。
Afr J Lab Med. 2023 Feb 6;12(1):1975. doi: 10.4102/ajlm.v12i1.1975. eCollection 2023.
5
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis.大规模结核分枝杆菌基因组分析揭示了与耐多药结核病相关的靶标和补偿性突变的程度。
Sci Rep. 2023 Jan 12;13(1):623. doi: 10.1038/s41598-023-27516-4.
6
Xpert MTB/RIF Ultra and mycobacterial culture in routine clinical care at a paediatric hospital.在一家儿科医院的常规临床护理中使用Xpert MTB/RIF Ultra和分枝杆菌培养。
S Afr J Infect Dis. 2022 Jun 20;37(1):398. doi: 10.4102/sajid.v37i1.398. eCollection 2022.
7
Whole-genome sequencing of for prediction of drug resistance.对 进行全基因组测序以预测药物耐药性。
Epidemiol Infect. 2022 Jan 7;150:e22. doi: 10.1017/S095026882100279X.
8
Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis.结核分枝杆菌分离株中的抗生素异质性耐药:系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2021 Oct 13;20(1):73. doi: 10.1186/s12941-021-00478-z.
9
Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study.喀麦隆利福平耐药结核分枝杆菌复合群菌株的传播模式:一项基于基因组流行病学的研究。
BMC Infect Dis. 2021 Aug 31;21(1):891. doi: 10.1186/s12879-021-06593-8.
10
Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan.巴基斯坦耐多药结核分枝杆菌突变的早期检测。
Sci Rep. 2021 Aug 18;11(1):16736. doi: 10.1038/s41598-021-96116-x.

本文引用的文献

1
Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.rpoB基因四个不同区域的突变可降低幽门螺杆菌对利福霉素的敏感性。
Antimicrob Agents Chemother. 2000 Jun;44(6):1713-5. doi: 10.1128/AAC.44.6.1713-1715.2000.
2
Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.rpoB基因起始部位的突变可使幽门螺杆菌和结核分枝杆菌对利福霉素产生耐药性。
Antimicrob Agents Chemother. 2000 Apr;44(4):1075-7. doi: 10.1128/AAC.44.4.1075-1077.2000.
3
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.结核分枝杆菌抗微生物剂耐药性的分子遗传学基础:1998年更新版
Tuber Lung Dis. 1998;79(1):3-29. doi: 10.1054/tuld.1998.0002.
4
Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.澳大利亚分离出的耐利福平结核分枝杆菌菌株的细菌学和分子分析。
J Clin Microbiol. 1999 Dec;37(12):3844-50. doi: 10.1128/JCM.37.12.3844-3850.1999.
5
Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.主要在亚洲国家分离出的耐利福平结核分枝杆菌菌株rpoB基因的突变及其通过线性探针分析的快速检测
J Clin Microbiol. 1999 Aug;37(8):2663-6. doi: 10.1128/JCM.37.8.2663-2666.1999.
6
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.在意大利分离出的耐多药结核分枝杆菌中的rpoB基因突变
J Clin Microbiol. 1999 Apr;37(4):1197-9. doi: 10.1128/JCM.37.4.1197-1199.1999.
7
Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampicin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa.采用自动DNA测序和线性探针分析对南非夸祖鲁-纳塔尔省结核分枝杆菌分离株利福平耐药性进行PCR-异源双链分析的比较
Microb Drug Resist. 1998 Winter;4(4):263-9. doi: 10.1089/mdr.1998.4.263.
8
Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.用于检测结核分枝杆菌对一线药物敏感性的分枝杆菌生长指示管的多中心评估。
J Clin Microbiol. 1999 Jan;37(1):45-8. doi: 10.1128/JCM.37.1.45-48.1999.
9
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.利福平、利福布汀和KRM-1648的抗分枝杆菌活性与结核分枝杆菌rpoB基因突变之间的关系。
J Antimicrob Chemother. 1998 Nov;42(5):621-8. doi: 10.1093/jac/42.5.621.
10
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.1994 - 1997年全球抗结核药物耐药性监测。世界卫生组织 - 国际防痨和肺部疾病联盟抗结核药物耐药性监测工作组
N Engl J Med. 1998 Jun 4;338(23):1641-9. doi: 10.1056/NEJM199806043382301.

耐利福平临床结核分枝杆菌分离株中I簇区域内外rpoB基因突变的频率。

Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

作者信息

Heep M, Brandstätter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S, Niemann S

机构信息

Institut fuer Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Regensburg, Germany.

出版信息

J Clin Microbiol. 2001 Jan;39(1):107-10. doi: 10.1128/JCM.39.1.107-110.2001.

DOI:10.1128/JCM.39.1.107-110.2001
PMID:11136757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC87688/
Abstract

The prevalence of recently described mutation V176F, located in the beginning of the rpoB gene and associated with rifampin resistance and the wild-type cluster I sequence, was determined by analyzing the distribution of rpoB mutations among 80 rifampin (RIF)-resistant Mycobacterium tuberculosis strains isolated in Germany during 1997. The most frequent rpoB mutations were changes in codon 456 (52 isolates, 65%), followed by changes in codon 441 (13 isolates, 16%) and codon 451 (11 isolates, 14%). The V176F mutation was detected in one isolate of the study population and in 5 of 18 RIF-resistant strains with no cluster I mutation from six previously published studies. In three isolates, a mixture of resistant and susceptible subpopulations (heteroresistance) prohibited the detection of rpoB mutations in the initial analysis; however, in these isolates, cluster I mutations could be verified after a passage on RIF-containing medium. IS6110 DNA fingerprinting of 76 strains revealed eight clusters comprising 27 strains with identical restriction fragment length polymorphism patterns that mainly also show identical rpoB mutations and identical or similar drug resistance patterns. In conclusion, our results indicate that the V176F mutation should be included in molecular tests for prediction of RIF resistance in M. tuberculosis. We further demonstrated that heteroresistance caused by a mixture of mycobacterial subpopulations with different susceptibilities to RIF may influence the sensitivity of molecular tests for detection of resistance.

摘要

通过分析1997年在德国分离出的80株耐利福平结核分枝杆菌菌株中rpoB基因突变的分布情况,确定了最近描述的位于rpoB基因起始部位、与利福平耐药性及野生型簇I序列相关的V176F突变的流行率。最常见的rpoB基因突变是密码子456的改变(52株,65%),其次是密码子441的改变(13株,16%)和密码子451的改变(11株,14%)。在本研究群体的1株菌株以及先前发表的6项研究中18株无簇I突变的耐利福平菌株中的5株中检测到了V176F突变。在3株菌株中,耐药和敏感亚群的混合(异质性耐药)在初始分析中妨碍了rpoB基因突变的检测;然而,在这些菌株中,在含利福平培养基上传代后可验证簇I突变。对76株菌株进行的IS6110 DNA指纹图谱分析显示,有8个簇,包含27株具有相同限制性片段长度多态性模式的菌株,这些菌株主要也显示相同的rpoB突变以及相同或相似的耐药模式。总之,我们的结果表明,V176F突变应纳入用于预测结核分枝杆菌利福平耐药性的分子检测中。我们还进一步证明,由对利福平敏感性不同的分枝杆菌亚群混合引起的异质性耐药可能会影响检测耐药性的分子检测的敏感性。